Delong Liu
- Molecular Biology top 2%
- Oncology top 0.5%
- Immunology top 1%
- Genetics top 0.5%
- Hematology top 0.5%
- Co-authors
- Shundong CangYongping SongGuoqing WeiJuanjuan ZhaoNikhil MukhiAkintunde AkinleyeMuhammad FurqanJingjing Wu
- Topics
- Acute Myeloid Leukemia Research (30 papers)CAR-T cell therapy research (30 papers)Lymphoma Diagnosis and Treatment (29 papers)
- Cited by
- OncologyGeneticsHematology
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Delong Liu
181 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Biology 3.9k
- Oncology 3.9k
- Immunology 1.7k
- Genetics 1.3k
- Hematology 1.3k
Countries citing papers authored by Delong Liu
This map shows the geographic impact of Delong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delong Liu more than expected).
Fields of papers citing papers by Delong Liu
This network shows the impact of papers produced by Delong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delong Liu. The network helps show where Delong Liu may publish in the future.
Co-authorship network of co-authors of Delong Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Delong Liu. A scholar is included among the top collaborators of Delong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delong Liu. Delong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 93 | |
| 10 | 19 | |
| 11 | 13 | |
| 12 | 20 | |
| 13 | 124 | |
| 14 | 19 | |
| 15 | 8 | |
| 16 | 221 | |
| 17 | 4 | |
| 18 | 236 | |
| 19 | 5 | |
| 20 | 11 |
About Delong Liu
Delong Liu is a scholar working on Hematology, Genetics and Oncology, having authored 189 papers that have together received 9.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), CAR-T cell therapy research (30 papers) and Lymphoma Diagnosis and Treatment (29 papers). The work is most often cited by research in Oncology (3.9k citations), Genetics (1.3k citations) and Hematology (1.3k citations). Delong Liu has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Shundong Cang, Yongping Song, Yongping Song, Guoqing Wei, Juanjuan Zhao, Nikhil Mukhi, Akintunde Akinleye, Muhammad Furqan, Jingjing Wu and Kemeng Wang. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.